Effect of erythromycin on human biliary motility

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 3, 1996, Pages 421-426

  Wehrmann, T ^a   Pfeltzer, C ^a   Caspary, W F ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; ERYTHROMYCIN LACTOBIONATE;

ABDOMINAL CRAMP; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; ENDOSCOPY; FEMALE; GALLBLADDER EMPTYING; GALLBLADDER MOTILITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; ODDI SPHINCTER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VATER PAPILLA STENOSIS;

ADULT; ANTI-BACTERIAL AGENTS; CHOLECYSTOGRAPHY; ERYTHROMYCIN; FEMALE; GALLBLADDER; GALLBLADDER EMPTYING; HUMANS; MALE; MANOMETRY; MIDDLE AGED; SPHINCTER OF ODDI;

EID: 0029897019     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0953-0673.1996.00421.x     Document Type: Article

References (17)

1. Catnach SM, Fairclough PD. Erythromycin and the gut. Gut 1992; 33: 397-401.
2. Weber FH, Richards RD, McCallum RW. Erythromycin: a motilin agonist and gastrointestinalprokinetic agent. Am J Gastroenterol 1993; 88: 485-90.
3. Peeters TL. Erythromycin and other macrolides as prokinetic agents. Gastroenterology 1993; 105: 1886-96
4. Peeters TL, Matthijs G, Depoortere I, et al. Erythromycin is a motilin receptor agonist. Am J Physiol 1989; 257: G470-4
5. Catnach SM, Fairclough PD, Trembath RC, et al. Effect of oral erythromycin on gall-bladder motility in normal subjects and subjects with gallstones. Gastroenterology 1992; 102: 2071-6.
6. Fiorucci S, Scionti L, Bosso R, et al. Effect of erythromycin on gall bladder emptying in diabetic patients with or without autonomie neuropathy and high levels of motilin. Dig Dis Sci 1992; 37: 1671-7.
7. Catnach SM, Ballinger AB, Stevens M, et al. Erythromycin induces supranormal gall-bladder contraction in diabetic autonomie neuropathy. Gut 1993; 34: 1123-7.
8. Cuer JC, Dapoigny M, Bommelaer G. The effect of midazolam on sphincter of Oddi motility. Endoscopy 1993; 39: 25-8.
9. Dodds WJ, Groh WJ, Darweesh RMA, et al. Sonographic measurement of gall-bladder volume. Am J Roentgenol 1985; 145: 1009-11.
10. Hogan WJ, Geenen JE. Biliary dyskinesia. Endoscopy 1988; 20: 179-83.
11. Baker RA, Saccone GTP, Costi D, Thune A, Toouli J. Motilin and erythromycin enhance the in vitro contractile activity of the sphincter of Oddi of the Australian Brush tatled Possum. Naunyn Schmiedeberg's Arch Pharmacol 1992; 345: 71-7.
12. Saccone GTP, Liu YF, Thune A, et al. Erythromycin and motilin stimulate sphincter of Oddi motility and inhibit transsphincteric flow in the Australian possum. Naunyn Schmiedeberg's Arch Pharmacol 1992; 346: 701-6.
13. Kaufman HS, Ahrendt SA, Pitt HA, Lillemoe KD. The effect of erythromycin on motility of the duodenum, sphincter of Oddi, and gall-bladder in the prairie dog. Surgery 1993; 114: 543-8.
14. Strunz U, Domschke W, Mitznegg P, et al. Analysis of the motor effects of 13-norleucine motilin on the rabbit, guinea pig, rat and human alimentary tract in vitro. Gastroenterology 1975; 68: 1485-91.
15. Takahashi I, Suzuki T, Aizawa I, Itoh Z. Comparison of gall-bladder contractions induced by motilin and cholecystokinin in dogs. Gastroenterology 1982; 82: 419-24.
16. Behar J, Biancani P. Effects and mechanisms of action of motilin on the cat sphincter of Oddi. Gastroenterology 1988; 95: 1099-105.
17. Ruffolo TA, Sherman S, Lehman GA, Hawes RH. Gall-bladder ejection fraction and its relationship to sphincter of Oddi dysfunction. Dig Dis Sci 1994; 39: 289-92.